New-Generation Devices Aid Growth of Global ECG Devices Market
|
By HospiMedica International staff writers Posted on 22 Aug 2019 |
The global electrocardiography devices (ECG) market is projected to grow at a CAGR of over 6% over the forecast period 2019-2023, driven primarily by technological advances, which have helped in developing easy-to-use devices with reduced size and enhanced portability. The market growth is further aided by the increasing prevalence of cardiovascular disease (CVD) and their growing awareness. However, the high cost of EVG devices, increasing demand for refurbished ECG devices and lack of skilled clinicians with expertise in ECG could hamper the growth of the ECG market over the forecast period.
These are the latest findings of Research and Markets, (Dublin, Ireland), a global market research company.
In addition to reduced size and enhanced portability, the new-generation ECG devices also incorporate advanced algorithms, which provide high-fidelity data to support better clinical decisions. Additionally, the latest ECG devices incorporate various workflow improvement features, such as simplified step-by-step operation, touch-screen systems, and better connectivity with ECG management systems. Moreover, technological advances in sensors now allow recording of electrical impulses from the heart in the absence of conventional ECG machines. Several technologies are now wearable and can monitor and record cardiac impulses for weeks or even months. These devices are increasingly being adopted in out-of-hospital settings such as households and public places. These developments are expected to have a positive impact on the growth of the global ECG market.
In 2018, the resting ECG devices segment held a significant share and is expected to continue dominating the global ECG market over the forecast period due to the increasing focus on early diagnosis and disease prevention, rising number of resting ECG procedures and technological advances.
Related Links:
Research and Markets
These are the latest findings of Research and Markets, (Dublin, Ireland), a global market research company.
In addition to reduced size and enhanced portability, the new-generation ECG devices also incorporate advanced algorithms, which provide high-fidelity data to support better clinical decisions. Additionally, the latest ECG devices incorporate various workflow improvement features, such as simplified step-by-step operation, touch-screen systems, and better connectivity with ECG management systems. Moreover, technological advances in sensors now allow recording of electrical impulses from the heart in the absence of conventional ECG machines. Several technologies are now wearable and can monitor and record cardiac impulses for weeks or even months. These devices are increasingly being adopted in out-of-hospital settings such as households and public places. These developments are expected to have a positive impact on the growth of the global ECG market.
In 2018, the resting ECG devices segment held a significant share and is expected to continue dominating the global ECG market over the forecast period due to the increasing focus on early diagnosis and disease prevention, rising number of resting ECG procedures and technological advances.
Related Links:
Research and Markets
Latest Business News
- Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
- B. Braun Acquires Digital Microsurgery Company True Digital Surgery
- CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
- Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
- Medtronic Partners with Corsano to Expand Acute Care & Monitoring Portfolio in Europe
- Expanded Collaboration to Transform OR Technology Through AI and Automation
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
- Boston Scientific Acquires Medical Device Company SoniVie
- 2026 World Hospital Congress to be Held in Seoul
- Teleflex to Acquire BIOTRONIK’s Vascular Intervention Business
- Philips and Mass General Brigham Collaborate on Improving Patient Care with Live AI-Powered Insights
- Arab Health 2025 Celebrates Landmark 50th Edition
- Boston Scientific Acquires Medical Device Company Intera Oncology
- MEDICA 2024 to Highlight Hot Topics of MedTech Industry
- Start-Ups To Once Again Play Starring Role at MEDICA 2024
- Boston Scientific to Acquire AFib Ablation Company Cortex
Channels
Critical Care
view channel
Earlier Blood Transfusion Could Reduce Heart Failure and Arrhythmia in Heart Disease Patients
Blood loss during or after surgery can place significant stress on people with heart disease, increasing the risk of dangerous complications. Transfusions are often delayed until hemoglobin levels fall... Read more
'Smart' Shirt Detects Epileptic Seizures in Real Time
Epilepsy affects roughly one in every 100 people worldwide, causing seizures that can range from subtle episodes to severe convulsions and loss of consciousness. These events arise from excessive electrical... Read moreSurgical Techniques
view channel
Ablation Reduces Stroke Risk Associated with Atrial Fibrillation
Atrial fibrillation (AFib) greatly increases the risk of stroke, blood clots, heart failure, and death, and millions of people in the U.S. are expected to be affected in the coming years.... Read more
Optical Tracking Method Identifies Target Areas in Robot-Assisted Neurosurgery
Epilepsy occurs when nerve cells misfire and produce uncontrolled electrical bursts in the brain, leading to seizures. While most patients respond to medication, about 30% require more advanced intervention.... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel







